UGI CORP /PA/ 8-K

What Happened

• On May 12, 2026, UGI Corporation (UGI) reported that its indirect, wholly owned subsidiary UGI International, LLC commenced a private offering of €300,000,000 aggregate principal amount of senior notes under exemptions to the U.S. Securities Act.
• UGI International has made an investor presentation available to prospective investors; that presentation was furnished under Regulation FD and is included as Exhibit 99.1 to the Form 8-K. A related press release was furnished as Exhibit 99.2.

Key Details

• Offering amount: €300,000,000 in senior notes; private placement subject to market conditions (may not be consummated).
• Date filed: May 12, 2026.
• Intended use of net proceeds (if the Offering occurs): repay short-term borrowings under UGI International’s senior unsecured revolving credit facility (including borrowings tied to a dividend contributed to AmeriGas), repay other outstanding amounts under the Revolving Credit Facility, partially prepay borrowings under UGI International’s senior unsecured term loan, pay related fees and expenses, with any remainder for general corporate purposes.
• The offering is not conditioned on AmeriGas repaying an intercompany loan; if that repayment is not received, UGI International expects to reduce planned repayments of Revolving Credit Facility and/or Term Loan borrowings.
• The investor presentation furnished under Regulation FD is “furnished” (not “filed”) and thus is not subject to Section 18 liability unless later specifically incorporated by reference.

Why It Matters

• This potential debt offering is a financing action that could refinance short-term borrowings and affect UGI International’s and UGI’s net debt and liquidity profile if completed.
• Investors should note the offering is conditional on market conditions and may not occur, and planned uses of proceeds depend in part on intercompany repayments that are not guaranteed.
• The filing furnishes supplemental investor materials (Regulation FD) and includes forward-looking statements; review UGI’s recent 10-K/10-Q for broader risk factors and the press release/investor presentation for additional details.